Tuesday, January 3, 2017

BRIEF-Inotek announces top-line results for MATRX-1

* Inotek announces top-line results for matrx-1, first phase

3 trial of trabodenoson for glaucoma

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)